Project content: The project will build a medical research and development zone, a medical testing zone, a medical production zone and a medical industry incubation center, introduce Class I and II medical device manufacturers, and build an advanced medical equipment manufacturing zone; We will introduce bio pharmaceutical manufacturing enterprises and build a pharmaceutical production and manufacturing zone that integrates the processing and preparation of traditional Chinese medicines.
Total investment: 500 million yuan.
Cooperation mode: sole proprietorship or joint venture.
Market forecast and investment return analysis: The biomedical industry is one of China's strategic emerging industries. There are rich Chinese herbal medicine resources such as forsythia suspensa and scutellaria baicalensis in the western mountains of Hancheng. The high-tech zone has introduced Hancheng Haotai Huayuan Pharmaceutical Co., Ltd., Shaanxi Enbeikang Biotechnology Co., Ltd., Hancheng Minghong Biological Co., Ltd. and other biomedical enterprises. Our city has introduced projects such as Xicheng Pharmaceutical Intermediary. The biomedical industrial park project will further realize the large-scale and park oriented development of the pharmaceutical industry in our city, and accelerate the formation of a biomedical industrial cluster with a certain scale and influence in our city and surrounding areas.